Rare disease news, mapped to the diseases behind the headlines. AI-classified across pipeline, policy, funding, science, and community.
Be among the first to receive Kisho Intelligence Briefings
Showing news related to
Showing 1–1 of 1 stories
A case study reports complete remission in a patient with advanced hepatocellular carcinoma following sequential therapy with durvalumab and cabozantinib. This finding may provide insights into effective treatment strategies for this challenging cancer.
Read full storyGet the week's most important rare disease developments — pipeline moves, policy changes, and funding signals — delivered to your inbox every Monday.
Free weekly briefing. Unsubscribe anytime.